Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Physical Chemistry Chemical Physics : PCCP
|
January 20, 2011
Synthesis of silica supported AuCu nanoparticle catalysts and the effects of pretreatment conditions for the CO oxidation reaction
J Chris Bauer, David Mullins, Meijun Li, et al.
Cancer Informatics
|
May 26, 2015
BioMiner: Paving the Way for Personalized Medicine
Chris Bauer, Karol Stec, Alexander Glintschert, et al.
Fluids and Barriers of the CNS
|
December 2, 2022
Is plasma amyloid-β 1-42/1-40 a better biomarker for Alzheimer's disease than AβX-42/X-40?
Hans-Wolfgang Klafki, Barbara Morgado, Oliver Wirths, et al.
Journal of Alzheimer'S Disease : JAD
|
October 19, 2020
Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum
Felix Menne, Carola Gertrud Schipke, Arne Klostermann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 16, 2019
Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease
Joana R F Santos, Chris Bauer, Johannes Schuchhardt, et al.
Journal of the American Chemical Society
|
April 8, 2009
Synthesis of CuPt nanorod catalysts with tunable lengths
Qingsheng Liu, Zhen Yan, Nathaniel L Henderson, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Organ-Specific Small Protein Networks in 100 kDa Ultrafiltrates: Functional Analysis and Implications for Neuroregenerative Medicine
Jakub Peter Slivka, Chris Bauer, Tasneem Halhouli, et al.
Journal of Alzheimer'S Disease : JAD
|
August 29, 2016
Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort
Hans-W Klafki, Henning Hafermann, Chris Bauer, et al.
Journal of Nephrology
|
May 14, 2022
Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database
Christoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.
BMC Bioinformatics
|
February 21, 2012
PPINGUIN: Peptide Profiling Guided Identification of Proteins improves quantitation of iTRAQ ratios
Chris Bauer, Frank Kleinjung, Dorothea Rutishauser, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Physical Chemistry Chemical Physics : PCCP
|
January 20, 2011
Synthesis of silica supported AuCu nanoparticle catalysts and the effects of pretreatment conditions for the CO oxidation reaction
J Chris Bauer, David Mullins, Meijun Li, et al.
Cancer Informatics
|
May 26, 2015
BioMiner: Paving the Way for Personalized Medicine
Chris Bauer, Karol Stec, Alexander Glintschert, et al.
Fluids and Barriers of the CNS
|
December 2, 2022
Is plasma amyloid-β 1-42/1-40 a better biomarker for Alzheimer's disease than AβX-42/X-40?
Hans-Wolfgang Klafki, Barbara Morgado, Oliver Wirths, et al.
Journal of Alzheimer'S Disease : JAD
|
October 19, 2020
Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum
Felix Menne, Carola Gertrud Schipke, Arne Klostermann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 16, 2019
Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease
Joana R F Santos, Chris Bauer, Johannes Schuchhardt, et al.
Journal of the American Chemical Society
|
April 8, 2009
Synthesis of CuPt nanorod catalysts with tunable lengths
Qingsheng Liu, Zhen Yan, Nathaniel L Henderson, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Organ-Specific Small Protein Networks in 100 kDa Ultrafiltrates: Functional Analysis and Implications for Neuroregenerative Medicine
Jakub Peter Slivka, Chris Bauer, Tasneem Halhouli, et al.
Journal of Alzheimer'S Disease : JAD
|
August 29, 2016
Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort
Hans-W Klafki, Henning Hafermann, Chris Bauer, et al.
Journal of Nephrology
|
May 14, 2022
Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database
Christoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.
BMC Bioinformatics
|
February 21, 2012
PPINGUIN: Peptide Profiling Guided Identification of Proteins improves quantitation of iTRAQ ratios
Chris Bauer, Frank Kleinjung, Dorothea Rutishauser, et al.
Page
of 5